Form 4 for OTLK Outlook Therapeutics, Inc.
Accepted 2026-08-14 20:57:45 ET · period of report 2026-08-14 · accession 0001104659-26-097406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 20:57 | 2026-08-14 | OTLK | Jahr Robert Charles | CEO, Dir | P - Purchase | — | +151.5K | 151.5K | New | — |
| D | 2026-08-14 20:57 | 2026-08-14 | OTLK | Jahr Robert Charles | CEO, Dir | P - Purchase | — | +151.5K | 151.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | P | A | 151,515 | — | 151,515 | D | — | — | (F1) On August 14, 2026, the reporting person acquired 151,515 shares of common stock and accompanying warrants to purchase 151,515 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant. |
| 2 | Derivative | Warrants (right to buy) | 2026-08-14 | P | A | 151,515 | — | 151,515 | D | $1.10 · 2026-08-14 to 2031-08-14 | 151,515 Common Stock | (F2) The warrants were exercisable immediately upon issuance and expire five years from the date of issuance, on August 14, 2031. (F1) On August 14, 2026, the reporting person acquired 151,515 shares of common stock and accompanying warrants to purchase 151,515 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant. |